Researchers Test Transplanted Pancreatic Cells to Restore Insulin Production in Type 1 Diabetes

A clinical trial is evaluating whether implanting insulin-producing cells under the skin could help people with Type 1 diabetes manage their condition. Here's what the early research shows.

cure researchbeta cellsadvancements

Key takeaways

Researchers are transplanting islet cells—clusters that include insulin-producing beta cells—into the forearms of people with Type 1 diabetes in a new clinical trial
These cells are placed just under the skin where they can potentially function like a natural pancreas
Current islet cell donations come from deceased donors, which limits availability; scientists are exploring whether lab-grown stem cells could provide a renewable source
This approach is in early testing stages with a small number of participants

What Are Islet Cells and Why Are They Important?

Islet cells are clusters found in the pancreas made up of four different cell types, including beta cells that produce insulin. In Type 1 diabetes, the immune system attacks and destroys these beta cells, leaving the body unable to regulate blood sugar. By transplanting healthy islet cells from donors into people with Type 1 diabetes, researchers hope to restore the body's natural ability to make and release insulin.

How Does the Trial Work?

The clinical trial involves implanting islet cells under the skin of the forearm. This location allows the transplanted cells to remain accessible while functioning similarly to how they would in the pancreas. The trial has enrolled eight people with Type 1 diabetes and is monitoring whether the transplanted cells can produce insulin and improve blood sugar control.

The Donor Shortage Challenge

Currently, islet cells for transplant come from deceased donors who meet specific criteria. While this source has proven effective, the number of available donors is limited, creating a significant bottleneck for expanding this treatment to more patients. This scarcity is one reason why researchers cannot yet treat large numbers of people.

Why Lab-Grown Cells Could Change Everything

To overcome the donor shortage, scientists are exploring whether stem cells grown in the laboratory could be developed into functional islet cells. If successful, researchers could generate as many cells as needed to treat more patients without relying on donor availability. This approach remains in early stages and requires further research to demonstrate safety and effectiveness.

Evidence label

Origin: YouTube / Diabetech (Video report). Evidence: Video report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.